Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy

João L Cavalcante1, Joaquim S Barboza, Harry M Lever

  • 1Cleveland Clinic Foundation, Department of Cardiovascular Medicine, Section of Cardiac Imaging, Cleveland, OH 44195, USA.

Insights

Hypertrophic cardiomyopathy (HCM) involves complex mitral valve issues affecting outflow tract obstruction. Understanding these abnormalities through advanced imaging is crucial for effective treatment and improved patient outcomes.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart condition.
  • Left ventricular outflow tract obstruction significantly impacts HCM symptoms and prognosis.
  • The mitral valve apparatus plays a critical role in HCM pathophysiology.

Purpose of the Study:

  • To review the role of the mitral apparatus in hypertrophic cardiomyopathy.
  • To emphasize the importance of multimodality imaging in assessing mitral abnormalities in HCM.
  • To highlight the clinical significance of these abnormalities for treatment and outcomes.

Main Methods:

  • Literature review focusing on hypertrophic cardiomyopathy and mitral valve abnormalities.
  • Discussion of advanced imaging modalities, particularly cardiac magnetic resonance.
  • Analysis of described mitral apparatus abnormalities in HCM patients.

Main Results:

  • Several mitral apparatus abnormalities are identified in HCM, including papillary muscle anomalies, abnormal leaflet lengths, and mitral regurgitation.
  • These abnormalities are key determinants of left ventricular outflow tract obstruction.
  • Multimodality imaging enhances the understanding of mitral valve involvement in HCM.

Conclusions:

  • The mitral valve apparatus is integral to HCM, influencing symptoms and outcomes.
  • Accurate assessment of mitral abnormalities using advanced imaging is essential for optimal surgical planning.
  • Ignoring mitral valve involvement can lead to suboptimal treatment and poorer patient results.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...